Sumatriptan and Naproxen sodium

DRUG2 trials

Sponsors

POZEN, GlaxoSmithKline

Conditions

Migraine DisordersMigraine Headaches

Phase 3

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

CompletedNCT00442221

POZENMigraine Headaches

Start: 2004-05-31End: 2004-08-31Target: 500Updated: 2007-03-01

Migraine Study in Adolescent Patients

CompletedNCT00843024

GlaxoSmithKlineMigraine Disorders

Start: 2008-12-31End: 2010-06-30Updated: 2017-01-18